UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KNL
2151
DELISTED
Knoll, Inc.
KNL
| $757K | ﹤0.01% |
45,879
+1,033
| +2% | +$16.9K |
|
2152
Amphastar Pharmaceuticals
AMPH
$916M
| $753K | ﹤0.01% |
41,087
| – | – |
|
|
AERI
2153
DELISTED
Aerie Pharmaceuticals
AERI
| $752K | ﹤0.01% |
42,076
| – | – |
|
2154
Photronics
PLAB
$1.93B
| $750K | ﹤0.01% |
58,347
-11,314
| -16% | -$137K |
|
2155
BRC Group Holdings
RILY
$289M
| $737K | ﹤0.01% |
+13,070
| New | +$705K |
|
2156
e.l.f. Beauty
ELF
$5.81B
| $736K | ﹤0.01% |
27,448
-447
| -2% | -$11.2K |
|
2157
Leslie's
LESL
$11M
| $736K | ﹤0.01% |
+1,503
| New | +$768K |
|
2158
Ituran Location and Control
ITRN
$1.05B
| $736K | ﹤0.01% |
34,653
| – | – |
|
|
CNST
2159
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $734K | ﹤0.01% |
31,369
+5,300
| +20% | +$161K |
|
|
EBSB
2160
DELISTED
Meridian Bancorp, Inc.
EBSB
| $733K | ﹤0.01% |
39,769
| – | – |
|
2161
Marten Transport
MRTN
$1.22B
| $731K | ﹤0.01% |
43,101
+1,118
| +3% | +$18.9K |
|
2162
Personalis
PSNL
$1.51B
| $731K | ﹤0.01% |
29,700
+11,800
| +66% | +$405K |
|
2163
Interparfums
IPAR
$3.94B
| $730K | ﹤0.01% |
10,296
+469
| +5% | +$31.8K |
|
|
OSG
2164
Octave Specialty Group
OSG
$222M
| $730K | ﹤0.01% |
43,600
| – | – |
|
2165
ProPetro Holding
PUMP
$1.35B
| $729K | ﹤0.01% |
68,382
| – | – |
|
2166
Celldex Therapeutics
CLDX
$3.28B
| $729K | ﹤0.01% |
35,377
+1,390
| +4% | +$31.9K |
|
2167
Ethan Allen Interiors
ETD
$603M
| $727K | ﹤0.01% |
26,326
-4,054
| -13% | -$102K |
|
2168
British American Tobacco
BTI
$128B
| $724K | ﹤0.01% |
18,679
| – | – |
|
|
NPTN
2169
DELISTED
NEOPHOTONICS CORP
NPTN
| $723K | ﹤0.01% |
60,488
+388
| +0.6% | +$4.4K |
|
2170
ACM Research
ACMR
$5.79B
| $722K | ﹤0.01% |
26,802
+600
| +2% | +$19.8K |
|
2171
Krystal Biotech
KRYS
$9.66B
| $722K | ﹤0.01% |
9,367
-1,300
| -12% | -$94.5K |
|
2172
BrightView Holdings
BV
$1.07B
| $721K | ﹤0.01% |
42,721
| – | – |
|
2173
Heartland Express
HTLD
$956M
| $719K | ﹤0.01% |
36,718
+6,290
| +21% | +$119K |
|
|
KDMN
2174
DELISTED
Kadmon Holdings, Inc.
KDMN
| $719K | ﹤0.01% |
184,720
+14,100
| +8% | +$64.6K |
|
2175
iShares MSCI Turkey ETF
TUR
$213M
| $717K | ﹤0.01% |
31,164
| – | – |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.